TTC22 as a potential prognostic marker and therapeutic target in pancreatic cancer: Insights into immune infiltration and epithelial‑mesenchymal transition.
Journal Information
Full Title: Oncol Lett
Abbreviation: Oncol Lett
Country: Unknown
Publisher: Unknown
Language: N/A
Publication Details
Related Papers from Same Journal
Transparency Score
3/6
50.0% Transparent
Transparency Indicators
Click on green indicators to view evidence textCore Indicators
Data Sharing
Code Sharing
COI Disclosure
Evidence found in paper:
"Competing interests The authors declare that they have no competing interests."
Funding Disclosure
Evidence found in paper:
"This study was supported by the National Natural Science Foundation of China (grant nos. 82072754 and 32170910), Jiangsu Provincial Key Research and Development Program (grant no. BE2018689), Natural Science Foundation of Jiangsu Province (grant no. BK20211124), Postgraduate Research & Practice Innovation Program of Jiangsu Province (grant no. KYCX22_3711), and Zhenjiang Key Research and Development Program (grant nos. SH2021037 and SH2018033)."
Protocol Registration
Open Access
Paper is freely available to read
Additional Indicators
Replication
Novelty Statement
Assessment Info
Tool: rtransparent
OST Version: N/A
Last Updated: Aug 05, 2025